Novavax, Inc. (FRA:NVV1)
Germany · Delayed Price · Currency is EUR 7.44
-0.50 (-6.24%)
At close: Jan 30, 2026
Novavax Market Cap
Novavax has a market cap or net worth of €1.21 billion as of January 30, 2026. Its market cap has decreased by -9.11% in one year.
Market Cap
1.21B
Enterprise Value
779.04M
Revenue
907.40M
Ranking
n/a
PE Ratio
4.15
Stock Price
€7.44
Market Cap Chart
Since July 25, 1996, Novavax's market cap has increased from 27.26M to 1.21B, an increase of 4,337.86%. That is a compound annual growth rate of 13.70%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 30, 2026 | 1.21B | 30.08% |
| Dec 31, 2025 | 930.05M | -25.24% |
| Dec 31, 2024 | 1.24B | 141.15% |
| Dec 29, 2023 | 515.85M | -37.63% |
| Dec 30, 2022 | 827.03M | -91.31% |
| Dec 31, 2021 | 9.51B | 185.25% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Merck KGaA | 54.59B |
| Siemens Healthineers AG | 47.05B |
| Bayer Aktiengesellschaft | 43.78B |
| Fresenius SE & Co. KGaA | 26.59B |
| SCHOTT Pharma AG & Co. KGaA | 2.16B |
| Dermapharm Holding SE | 1.88B |
| Redcare Pharmacy NV | 1.27B |
| Evotec SE | 1.10B |